Latest filing published 22 Dec 2016 for Valeant Pharmaceuticals International, Inc., €13k.
Anne Whitaker is a declared insider of Valeant Pharmaceuticals International, Inc., with filings sourced from SEDI. In total, 4 filings cover trades dated from 2 August 2016 to 5 December 2016.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 22 December 2016, the filings show a transaction worth €13k in Valeant Pharmaceuticals International, Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations